Furthermore, subsequent studies clarified that the administration of exogenous galectin-9 induced apoptosis of human malignant cells and immune responsible cells in vitro and in vivo, suggesting that galectin-9 can be a candidate anti-cancer agent based on the carbohydrate recognition function of this animal lectin [15,16]. This evidence concerns the gene LGALS9 and cancer.